skip to primary navigation skip to content

Robert Doubleday PhD

Robert Doubleday PhD

Director, Centre for Science and Policy (CSaP)

Senior Research Associate, Department of Geography


  • 2008-2010 Temporary University Lecturer, Department of Geography, University of Cambridge
  • 2006-2008 Senior Research Associate, Department of Geography, University of Cambridge
  • 2004-2006 Research Associate, Nanoscience Centre, University of Cambridge
  • 2000-2001 Visiting Fellow, Kennedy School of Government, Harvard University


  • PhD, Geography, University College London, 2005
  • MSc, Science and Technology Policy, University of Sussex, 1999
  • BSc, Chemistry, Imperial College London, 1997


Research at the Centre for Science and Policy carries out comparative empirical studies of the connections among science, policy and politics. It focuses on formal mechanisms of scientific advice and explores the roles these play in constituting political and epistemic authority.

My primary interests are in understanding the role of science and technology in contemporary societies, in particular the relationship between science and democracy. I explore collaborative methods of working with natural scientists and engineers to developing deeper shared understandings of the public and policy dimensions of research in science and technology.

Role of scientific advice in the policy process

I spent the 2009/10 academic year as an ESRC Placement Fellow at the Government Office for Science. My work there focused on policies to support greater engagement between academic research and public policy making: Strengthening Engagement between Government and Academia

Public dimensions of science and innovation

I was the principal investigator of a three-year Wellcome Trust funded project that studies the public dimensions of research policy and practice. The project involves policy analysis, laboratory studies and the development of novel collaborative methods: Social Laboratories: engaging with public dimensions of nanobiotechnology

Public engagement with nanotechnology

Building on my collaboration with the University of Cambridge's Nanoscience Centre I study public engagement with nanotechnologies and the links between engagement projects and science policy:

NanoJury UK: a citizens' jury that took place in 2005.

Nanotechnology Engagement Group:a project funded by the UK Office of Science and Innovation to advise government on lessons from public engagement projects on nanotechnology.


Publications - journal articles and book chapters

  • Doubleday, R and Wilsdon, J (2012) 'Beyond the great and good' Nature, 485: 301-302.
  • Sutherland, W.J., Bellingan, L., Bellingham, J.R., Blackstock, J.J., Bloomfield, R.M., Bravo, M., Cadman, V.M., Cleevely, D.D., Clements, A., Cohen, A.S., Cope, D.R., Daemmrich, A.A., Devecchi, C., Anadon, L.D., Denegri, S., Doubleday, R., Dusic, N.R., Evans, R.J., Feng, W.Y., Godfray, H.C.J., Harris, P., Hartley, S.E., Hester, A.J., Holmes, J., Hughes, A., Hulme, M., Irwin, C., Jennings, R.C., Kass, G.S., Littlejohns, P., Marteau, T.M., McKee, G., Millstone, E.P., Nuttall, W.J., Owens, S., Parker, M.M., Pearson, S., Petts, J., Ploszek, R., Pullin, A.S., Reid, G., Richards, K.S., Robinson, J.G., Shaxson, L., Sierra, L., Smith, B.G., Spiegelhalter, D.J., Stilgoe, J., Stirling, A., Tyler, C.P., Winickoff, D.E. and Zimmern, R.L. (In press) A collaboratively-derived science-policy research agenda. PLoSONE, 7(3): e31824.
  • Doubleday R and Wynne B (2011) 'Despotism and democracy in the UK: experiments in reframing relations between the state, science and citizens' in Jasanoff S (ed) Reframing Rights: Bioconstitutionalism in the Genetic Age, MIT Press: Cambridge, MA.
  • Doubleday R and Viseu A (2010) 'Questioning Interdisciplinarity: What Roles for Laboratory based Social Science' in Kjølberg K and Wickson F (eds) Nano Meets Macro: Social perspectives on nanoscale sciences and technologies, Pan Stanford Publishing: Singapore.
  • Doubleday R (2008) 'Ethical codes and scientific norms: the role of communication in maintaining the social contract for science' in Holliman R et al (eds) Practising Science Communication in the Information Age, Oxford University Press: Oxford.
  • Doubleday R (2007) 'The laboratory revisited: academic science and the responsible governance of nanotechnology' NanoEthics, 1(2): 167-176. doi:10.1007/s11569-007-0017-4
  • Doubleday R (2007) 'Risk, public engagement and reflexivity: alternative framings of the public dimensions of nanotechnology' Health Risk and Society, 9(2): 211-227. doi:10.1080/13698570701306930
  • Doubleday R (2007) 'Organizing Accountability: co-production of technoscientific and social worlds in a nanoscience laboratory' Area, 39(2): 166-175. doi:10.1111/j.1475-4762.2007.00742.x
  • Doubleday R (2004) 'Institutionalising NGO Dialogue at Unilever: framing the public as "consumer-citizens"', Science and Public Policy, 31(2): 117-126. doi:10.3152/147154304781780109
  • Doubleday R (2001) 'Knowledge and the Governance of Biotechnology', Notizie di Politeia, 17(62): 22-33.
  • Song Y, Connor DT, Doubleday R, Sorenson RJ, Sercel AD, Unangst PC, Roth BD, Gilbertsen RB, Chan K, Schrier DJ, Guglietta A, Bornemeier DA and Dyer RD (1999) 'Synthesis, Structure-Activity Relationships, and in Vivo Evaluations of Substituted Di-tert-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 1. Thiazolone and Oxazolone Series', Journal of Medicinal Chemistry, 42(7): 1151-1160. doi:10.1021/jm9805081
  • Song Y, Connor DT, Sercel AD, Sorenson RJ, Doubleday R, Unangst PC, Roth BD, Beylin VG, Gilbertsen RB, Chan K, Schrier DJ, Guglietta A, Bornemeier DA and Dyer RD (1999) 'Synthesis, Structure-Activity Relationships, and in Vivo Evaluations of Substituted Di-tert-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 2. 1,3,4- and 1,2,4-Thiadiazole Series', Journal of Medicinal Chemistry, 42(7): 1161-1169. doi:10.1021/jm980570y
  • Song Y, Connor DT, Sorenson RJ, Doubleday R, Sercel AD, Unangst PC, Gilbertsen RB, Chan K, Bornemeier DA and Dyer RD (1997) '2,6-di-tert-butylphenols: A new class of potent and selective PGHS-2 inhibitor', Inflammation Research, 46(2): 141-142.
  • Unangst PC, Capiris T, Connor DT, Doubleday R, Heffner TG, MacKenzie RG, Miller SR, Pugsley TA and Wise LD (1997) '(Aryloxy)alkylamines as selective human dopamine D-4 receptor antagonists: Potential antipsychotic agents', Journal of Medicinal Chemistry, 40(25): 4026- 4029. doi:10.1021/jm970422s

Publications - other

External activities